ESMO 2022 Conference Coverage
Playback speed
10 seconds
ESMO 2022 Updated Results From ADAURA: Osimertinib as Adjuvant Therapy in Patients With Resected EGFRm Stage IB–IIIA NSCLC
By
ESMO 2022 Conference Coverage
FEATURING
Tom John
By
ESMO 2022 Conference Coverage
FEATURING
Tom John
652 views
November 8, 2022
Comments 0
Login to view comments.
Click here to Login
Lung